Welcome to Paid Research Studies




  • Condition:   Barrett's Esophagus
    Intervention:  
    Sponsor:   Abramson Cancer Center of the University of Pennsylvania
    Recruiting

  • Condition:   Barrett's Esophagus
    Intervention:   Device: Sponge capsule
    Sponsors:   Mayo Clinic;   Exact Sciences Corporation
    Recruiting

  • Condition:   Barrett Esophagus
    Intervention:   Drug: KSP/QRH dimer
    Sponsor:   University of Michigan
    Recruiting

  • Condition:   Barrett's Esophagus
    Intervention:  
    Sponsor:   Mayo Clinic
    Recruiting

  • Condition:   Barrett Esophagus
    Intervention:   Device: Tethered Capsule Endomicroscopy (TCE)
    Sponsors:   Massachusetts General Hospital;   Columbia University;   Mayo Clinic;   Kansas City Veteran Affairs Medical Center;   National Institutes of Health (NIH);   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Barrett Esophagus
    Interventions:   Procedure: Esophagogastroduodenoscopy with high definition-white light end endoscopy (HD-WLE) and narrow band imaging (NBI);   Device: Olympus Disposable Distal Attachment Cap
    Sponsor:   Washington University School of Medicine
    Recruiting

  • Condition:   Barrett's Esophagus
    Intervention:   Device: Experimental OFDI Imaging
    Sponsors:   Massachusetts General Hospital;   National Institutes of Health (NIH);   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Barretts Esophagus With Dysplasia
    Intervention:   Drug: Alginates
    Sponsor:   Medical University of South Carolina
    Recruiting

  • Condition:   Barrett Esophagus
    Intervention:   Device: The Nvision VLE Imaging System
    Sponsors:   Mayo Clinic;   American Society for Gastrointestinal Endoscopy
    Recruiting

  • Conditions:   Barrett's Esophagus;   High-grade Dysplasia in Barrett Esophagus;   Low Grade Dysplasia in Barrett Esophagus
    Interventions:   Device: Hybrid argon plasma ablation (HAPC);   Device: Radiofrequency ablation (RFA)
    Sponsors:   Erbe Elektromedizin GmbH;   Erbe USA Incorporated;   Kansas City Veteran Affairs Medical Center;   Emissary International LLC
    Recruiting

  • Conditions:   Barrett's Esophagus;   Esophageal Cancer
    Interventions:   Procedure: Endoscopic eradication therapies (EET);   Procedure: Esophagectomy;   Drug: Chemotherapy;   Radiation: Radiation
    Sponsors:   University of Colorado, Denver;   Feinberg School of Medicine, Northwestern University;   University of California, Los Angeles;   H. Lee Moffitt Cancer Center and Research Institute;   California Pacific Medical Center
    Recruiting

  • Condition:   Barrett Esophagus Adenocarcinoma
    Interventions:   Procedure: Complete endoscopic resection at Day 1 and months 2, 4, 6 8 and month 10.;   Device: Endoscopic resection at month 2 and month 4
    Sponsor:   Institut Paoli-Calmettes
    Recruiting

  • Condition:   Barrett's Esophagus
    Intervention:   Device: OFDI Capsule Marking
    Sponsors:   Massachusetts General Hospital;   National Institutes of Health (NIH);   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Barrett Esophagus;   Esophageal Adenocarcinoma
    Intervention:   Device: Sponge Capsule
    Sponsor:   Mayo Clinic
    Not yet recruiting

  • Conditions:   Barrett's Esophagus;   Esophageal Adenocarcinoma
    Intervention:   Other: EMR and RFA effect on stem cell marker expression in BE/EAC
    Sponsor:   University of Oklahoma
    Recruiting

  • Conditions:   Barrett Esophagus;   Barrett Adenocarcinoma;   Esophagus Neoplasm
    Interventions:   Procedure: Endoscopic mucosal resection;   Procedure: Endoscopic submucosal dissection
    Sponsor:   Universitätsklinikum Hamburg-Eppendorf
    Recruiting

  • Condition:   Barretts Esophagus
    Intervention:  
    Sponsor:   Professor Michael Bourke
    Not yet recruiting

  • Condition:   Squamous Cell Carcinoma of the Esophagus
    Interventions:   Drug: Ramucirumab;   Drug: Paclitaxel
    Sponsors:   IKF Klinische Krebsforschung GmbH at Krankenhaus Nordwest;   Eli Lilly and Company;   Trium Analysis Online GmbH
    Recruiting

  • Condition:   Esophagus Squamous Cell Carcinoma
    Intervention:   Drug: raltitrexed
    Sponsor:   Huai'an First People's Hospital
    Recruiting

  • Condition:   Barretts Esophagus With Dysplasia
    Interventions:   Device: EndoRotor Mucosal Resection System;   Device: Continued Ablation
    Sponsor:   Interscope, Inc.
    Recruiting

  • Condition:   Barrett's Esophagus With Dysplasia
    Interventions:   Device: Mucosal Impedance;   Other: Research Biopsies;   Device: Volumetric Laser Endomicroscopy
    Sponsor:   Mayo Clinic
    Recruiting

  • Conditions:   Barrett's Esophagus;   Radiofrequency Ablation;   Gastroesophageal Reflux Disease
    Intervention:  
    Sponsors:   Matthias Paireder;   Medtronic - MITG
    Recruiting

  • Conditions:   Barrett Esophagus;   Esophageal Neoplasms;   Reflux Esophagitis
    Intervention:   Device: Endoscopy with Polyscope (Polydiagnost TM) coupled with Multi-Spectral Imaging light-source
    Sponsor:   University of Cambridge
    Recruiting

  • Condition:   Histologically Confirmed Unresectable or Metastatic Squamous Cell Carcinoma of the Esophagus Who Failed on Standard Treatment
    Intervention:   Drug: PDR001+MCS110
    Sponsor:   Yonsei University
    Not yet recruiting

  • Conditions:   Barrett's Esophagus;   Neoplasms;   Gastroesophageal Reflux
    Intervention:  
    Sponsors:   Midwest Biomedical Research Foundation;   Kansas City Veteran Affairs Medical Center
    Recruiting

  • Conditions:   Barrett's Esophagus;   Gastroesophageal Reflux Disease;   Esophageal Adenocarcinoma
    Intervention:  
    Sponsors:   Midwest Biomedical Research Foundation;   Kansas City Veteran Affairs Medical Center
    Recruiting

  • Condition:   Barrett Esophagus
    Intervention:   Procedure: Radiofrequency ablation (RFA)
    Sponsor:   Guy's and St Thomas' NHS Foundation Trust
    Recruiting

  • Condition:   Barrett Esophagus
    Intervention:  
    Sponsors:   Geisinger Clinic;   Medical University of South Carolina;   Long Island Jewish Medical Center;   Pentax Medical;   Virginia Commonwealth University
    Recruiting

  • Condition:   Barrett's Esophagus
    Intervention:   Drug: Proflavine, high resolution imaging
    Sponsors:   Anandasabapathy, Sharmila, M.D.;   William Marsh Rice University;   Baylor College of Medicine
    Recruiting

  • Condition:   Barrett's Esophagus
    Intervention:   Other: Biopsies with histopathology
    Sponsor:   Institute for Clinical and Experimental Medicine
    Recruiting

  • Condition:   Barrett's Esophagus
    Intervention:  
    Sponsor:   Professor Michael Bourke
    Recruiting

  • Condition:   Barrett Esophagus
    Interventions:   Drug: Bevacizumab-IRDye800CW;   Diagnostic Test: Fluorescence endoscopy
    Sponsors:   University Medical Center Groningen;   Helmholtz Zentrum München
    Not yet recruiting

  • Condition:   Esophagus Cancer
    Intervention:   Procedure: preoperative enhanced chest CT examination
    Sponsor:   Beijing Cancer Hospital
    Recruiting

  • Conditions:   Barretts Esophagus With Low Grade Dysplasia;   Dysplasia;   Intestinal Metaplasia
    Interventions:   Diagnostic Test: Acetic acid chromoendoscopy;   Diagnostic Test: Seattle protocol
    Sponsor:   Coordinación de Investigación en Salud, Mexico
    Recruiting

  • Conditions:   Barrett Esophagus;   Esophageal Cancer
    Intervention:   Diagnostic Test: endoscopy
    Sponsors:   University of Exeter;   University of Bristol;   Gloucestershire Hospitals NHS Foundation Trust
    Not yet recruiting

  • Conditions:   Adenocarcinoma Esophagus;   Adenocarcinoma of the Gastroesophageal Junction
    Intervention:   Drug: Sequential FLOT followed by chemoradiation
    Sponsors:   University of Colorado, Denver;   National Cancer Institute (NCI)
    Not yet recruiting

  • Conditions:   Small Cell Carcinoma of Esophagus;   Advanced Cancer
    Intervention:   Drug: Toripalimab
    Sponsor:   Sun Yat-sen University
    Recruiting

  • Condition:   Esophagus
    Interventions:   Procedure: Endoscopic Ultrasound-Guided Fine-Needle Aspiration (EUS-FNA);   Procedure: Contrast-Enhanced Ultrasound;   Procedure: Fine-Needle Aspiration;   Drug: Sonazoid (Perflubutane)
    Sponsors:   Sidney Kimmel Cancer Center at Thomas Jefferson University;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Oesophageal Cancer;   Barrett Esophagus;   Barretts Esophagus With Dysplasia
    Intervention:   Diagnostic Test: Breath test
    Sponsors:   Imperial College London;   Guts UK Charity;   University College London Hospitals NHS Foundation Trust;   Guy's and St Thomas' NHS Foundation Trust;   Oxford University Hospitals NHS Trust;   Nottingham University Hospitals NHS Trust;   University Hospital Birmingham NHS Foundation Trust;   Salford Royal NHS Foundation Trust;   London North West Healthcare NHS Trust
    Not yet recruiting

  • Conditions:   Early Gastric Cancer;   Barrett Esophagus
    Interventions:   Diagnostic Test: Linked Color Imaging;   Diagnostic Test: White Light Imaging
    Sponsors:   Changi General Hospital;   Singapore General Hospital
    Recruiting

  • Conditions:   Barrett Esophagus;   Esophageal Stenosis
    Interventions:   Drug: Prednisolone;   Drug: Placebo Oral Tablet
    Sponsor:   Professor Michael Bourke
    Not yet recruiting

  • Condition:   Esophagus Cancer
    Intervention:   Other: Non interventional study
    Sponsors:   Nantes University Hospital;   LLTech
    Recruiting

  • Conditions:   Adenocarcinoma of the Oesophagus;   Adenocarcinoma of the Oesophago-gastric Junction;   Oesophageal Tumours;   Junctional Tumours;   Oesophageal Cancer
    Interventions:   Drug: Epirubicin;   Drug: Cisplatin / Oxaliplatin;   Drug: 5 Flourouracil/ Capecitabine;   Radiation: (41.4 Gy/23 fractions);   Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Docetaxel;   Drug: Oxaliplatin;   Drug: Leucovorin;   Drug: 5-Fluorouracil
    Sponsors:   Cancer Trials Ireland;   Southampton Clinical Trials Unit;   Region H Rigshospitalet;   Centre Hospitalier Régional, Universitaire de Lille
    Recruiting

  • Condition:   Esophagus Cancer
    Intervention:   Radiation: Proton radiation
    Sponsor:   Loma Linda University
    Recruiting

  • Condition:   Perforation Esophagus
    Intervention:   Device: VACStent
    Sponsor:   University Hospital of Cologne
    Not yet recruiting

  • Condition:   Cancer of Esophagus
    Intervention:   Device: impedance
    Sponsor:   Sana Klinikum Offenbach
    Not yet recruiting

  • Condition:   Eosinophilic Esophagitis
    Intervention:   Device: SECM Capsule
    Sponsors:   Massachusetts General Hospital;   National Institutes of Health (NIH);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
    Recruiting

  • Condition:   Eosinophillic Esophagitis
    Intervention:   Device: SECM capsule
    Sponsor:   Massachusetts General Hospital
    Not yet recruiting

  • Condition:   Intubation Complication
    Intervention:   Other: Maneuvers for occluding esophagus
    Sponsor:   SMG-SNU Boramae Medical Center
    Not yet recruiting

  • Conditions:   Esophageal Diseases;   Esophagus SCC
    Intervention:   Device: Cytosponge™
    Sponsors:   International Agency for Research on Cancer;   Kilimanjaro Clinical Research Institute;   University of Cambridge
    Not yet recruiting

  • Conditions:   Barrett Esophagus;   Esophageal Dysplasia;   Esophageal Adenocarcinoma
    Intervention:   Procedure: Diagnostic Test
    Sponsor:   CDx Diagnostics
    Recruiting

  • Condition:   Optical Enhancement Endoscopy
    Interventions:   Device: first OE;   Device: first WLI
    Sponsor:   Shandong University
    Recruiting

  • Condition:   Non-Small Cell Lung Cancer
    Interventions:   Radiation: Conventional radiotherapy;   Radiation: Esophageal-Sparing Intensity-Modulated Radiotherapy
    Sponsor:   Lawson Health Research Institute
    Recruiting

  • Condition:   Head & Neck Cancer
    Intervention:   Drug: nanoliposomal irinotecan
    Sponsors:   National Health Research Institutes, Taiwan;   China Medical University Hospital;   Tri-Service General Hospital;   Taipei Veterans General Hospital, Taiwan;   National Cheng-Kung University Hospital
    Not yet recruiting

  • Conditions:   Barrett's Esophagus Without Dysplasia;   Barrett's Esophagus With Dysplasia;   Barrett's Esophagus With Low Grade Dysplasia;   Barrett's Esophagus With High Grade Dysplasia;   Barrett's Esophagus With Dysplasia, Unspecified
    Interventions:   Diagnostic Test: IRIS (Intelligent real-time image segmentation);   Diagnostic Test: VLE (Volumetric laser endomicroscopy)
    Sponsors:   Northwell Health;   NinePoint Medical
    Recruiting

  • Conditions:   Esophagus Cancer;   Esophagogastric Junction Cancer
    Interventions:   Device: MRI and CT;   Radiation: Ratiotherapy;   Drug: Paclitaxel, platinum-based drug
    Sponsor:   Chinese Academy of Medical Sciences
    Recruiting

  • Conditions:   Gastric Cancer;   Esophagus Cancer
    Intervention:   Drug: Oxaliplatin+Capecitabine+Pembrolizumab
    Sponsors:   Duke University;   Merck Sharp & Dohme Corp.
    Recruiting

  • Conditions:   Esophagus Adenocarcinoma;   Esophagus Squamous Cell Carcinoma;   Gastroesophageal Junction Adenocarcinoma
    Intervention:   Drug: Itraconazole
    Sponsor:   Dallas VA Medical Center
    Recruiting

  • Conditions:   Cancer of Esophagus;   Cancer, Lung
    Interventions:   Procedure: whole body electromyostimulation exercise;   Procedure: protein-rich nutrition therapy
    Sponsor:   University of Erlangen-Nürnberg Medical School
    Recruiting

  • Conditions:   Esophagus Cancer, Adenocarcinoma;   Stomach Cancer, Adenocarcinoma
    Interventions:   Drug: Rucaparib;   Drug: Ramucirumab;   Drug: Nivolumab
    Sponsors:   Anwaar Saeed;   Bristol-Myers Squibb;   Clovis Oncology, Inc.
    Not yet recruiting

  • Conditions:   Barrett Esophagus;   Dysplasia;   Esophageal Adenocarcinoma;   Esophageal Squamous Cell Carcinoma;   Gastroesophageal Reflux Disease;   Metaplasia
    Interventions:   Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Device: Swallowable Sponge Cell Sampling Device
    Sponsors:   OHSU Knight Cancer Institute;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Esophagus Cancer;   Esophageal Cancer;   Cancer of the Esophagus
    Interventions:   Radiation: Intensity Modulated Radiation Therapy;   Drug: FOLFOX regimen;   Other: MD Anderson Symptom Inventory (MDASI)-Plus module;   Other: EuroQol (EQ-5D);   Other: SF-12;   Other: MOS Social Support Measure;   Other: CES-D;   Procedure: Blood for ctDNA;   Procedure: Urine for ctDNA;   Procedure: Blood for SCCA
    Sponsor:   Washington University School of Medicine
    Not yet recruiting

  • Conditions:   Esophagus Cancer;   Esophageal Cancer;   Cancer of the Esophagus
    Interventions:   Radiation: Proton beam therapy;   Other: Patient-Reported Outcome Measures
    Sponsor:   Washington University School of Medicine
    Recruiting

  • Conditions:   Barrett Esophagus;   Gastroesophageal Reflux;   Esophageal Dysplasia;   Esophageal Diseases
    Intervention:  
    Sponsors:   CDx Diagnostics;   University of North Carolina, Chapel Hill
    Recruiting

  • Conditions:   Adenocarcinoma of the Esophagus;   Adenocarcinoma of the Gastroesophageal Junction;   Adenocarcinoma of the Gastric Cardia;   Stage IIIA Esophageal Cancer;   Stage IIIB Esophageal Cancer;   Stage IIIC Esophageal Cancer
    Interventions:   Drug: oxaliplatin;   Drug: leucovorin calcium;   Drug: fluorouracil;   Procedure: therapeutic conventional surgery;   Radiation: radiation therapy;   Drug: carboplatin;   Drug: paclitaxel
    Sponsors:   Case Comprehensive Cancer Center;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Sarcoma;   Rectal Carcinoma;   Esophagus Cancer
    Intervention:   Radiation: Standard treatment
    Sponsor:   Centre Leon Berard
    Recruiting

  • Conditions:   Cancer of Pancreas;   Cancer of Stomach;   Cancer of Esophagus
    Intervention:   Other: Anticipatory care planning letter
    Sponsors:   NHS Lothian;   NHS Fife
    Recruiting

  • Conditions:   Esophageal Dysfunction;   Pylorus Dysfunction
    Intervention:   Device: EndoFLIP
    Sponsor:   Hospices Civils de Lyon
    Recruiting

  • Conditions:   Adenocarcinoma of the Oesophagus;   Adenocarcinoma of the Gastro-oesophageal Junction;   Adenocarcinoma of the Stomach
    Interventions:   Drug: Capecitabine;   Drug: MEDI4736;   Drug: Trastuzumab;   Drug: Rucaparib
    Sponsors:   Royal Marsden NHS Foundation Trust;   MedImmune LLC;   Clovis Oncology, Inc.
    Recruiting

  • Condition:   Morbid Obesity
    Intervention:   Diagnostic Test: Gastroscopy
    Sponsor:   University Hospital, Basel, Switzerland
    Recruiting

  • Conditions:   Leakage After Esophagectomy;   Leakage After Gastrectomy;   Perforation of the Esophagus
    Intervention:   Device: Eso-SPONGE® vacuum treatment
    Sponsors:   Aesculap AG;   Universitätsklinikum Kiel
    Recruiting

  • Conditions:   Esophagogastric Cancer;   Moderate to Severe Dysphagia
    Intervention:   Drug: WST 11-mediated VTP therapy
    Sponsors:   Memorial Sloan Kettering Cancer Center;   Weizmann Institute of Science;   Steba Biotech S.A.
    Recruiting

  • Conditions:   Malignant Pleural Mesotheliomas NOS;   Esophageal Cancers NOS;   Lung Cancer NOS;   Thoracic Cancers;   Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
    Intervention:  
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Dysphagia;   Airway Aspiration;   Airway Penetration
    Interventions:   Other: Slower Flow Rate;   Other: Thickened Formula
    Sponsors:   Sudarshan Jadcherla;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   Ohio State University;   Medical College of Wisconsin
    Recruiting

  • Condition:   Esophageal Cancer
    Interventions:   Procedure: Robotic esophagectomy;   Procedure: Thoracolaparoscopic esophagectomy
    Sponsor:   GEM Hospital & Research Center
    Recruiting

  • Conditions:   Postoperative Complications;   Physical Activity;   Surgery--Complications
    Interventions:   Other: Control;   Other: Exercise - HIIT Intervention
    Sponsors:   University of Dublin, Trinity College;   Health Research Board, Ireland;   Medical Research Charities Group Ireland
    Not yet recruiting

  • Conditions:   Caustic Esophageal Injury;   Esophageal Stenosis;   Pharyngeal Stenosis
    Interventions:   Drug: Methylprednisolone;   Other: Placebo
    Sponsor:   Assistance Publique - Hôpitaux de Paris
    Not yet recruiting

  • Conditions:   Squamous Carcinoma;   Head and Neck Cancer;   Anal Cancer;   Lung Cancer;   Esophageal Cancer;   Cervix Cancer
    Intervention:  
    Sponsors:   Umeå University;   Lund University
    Recruiting

  • Conditions:   Atrial Fibrillation;   Catheter Ablation;   Esophageal Fistula;   Esophageal Diseases;   Arrhythmias, Cardiac
    Intervention:   Device: EnsoETM
    Sponsor:   Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
    Recruiting

  • Condition:   Esophageal Neoplasm
    Interventions:   Device: Endodrill Biopsy;   Device: Conventional Biopsy forceps
    Sponsor:   Region Skane
    Recruiting

  • Conditions:   Esophagus Cancer;   Hepatoma;   Glioma;   Gastric Cancer
    Intervention:   Biological: CAR-T/TCR-T cells immunotherapy
    Sponsors:   Shenzhen BinDeBio Ltd.;   Henan Provincial Hospital
    Recruiting

  • Conditions:   Capsule Endoscopy;   Cancer of Stomach;   Cancer of Esophagus;   Health Policy
    Intervention:   Other: Medical Consortium
    Sponsor:   Yanqing Li
    Recruiting

  • Conditions:   GORD;   Oesophageal Cancer;   Oesophageal Reflux;   Gastric Cancer;   Gastro Esophageal Reflux;   Oesophageal Carcinoma;   Barrett Esophagus;   Esophagitis
    Intervention:   Diagnostic Test: No intervention but patients are undergoing an upper GI endoscopy and biopsies for clinical purposes
    Sponsor:   Imperial College London
    Recruiting

  • Conditions:   Esophageal Adenocarcinoma;   Esophagus SCC;   Cholangiocarcinoma;   Urothelial/Bladder Cancer, Nos;   Endometrial Cancer
    Intervention:   Drug: Abemaciclib
    Sponsors:   Jules Bordet Institute;   Eli Lilly and Company
    Recruiting

  • Conditions:   Circulatory; Change;   Microcirculation
    Intervention:  
    Sponsor:   Oslo University Hospital
    Recruiting

  • Conditions:   Cancer;   Esophagus Squamous Cell Carcinoma;   Squamous Cell Carcinoma of the Head and Neck;   Anal Canal Squamous Cell Carcinoma;   Metastatic Cancer
    Intervention:  
    Sponsor:   University Health Network, Toronto
    Recruiting

  • Conditions:   Oncology;   Breast Cancer;   Prostate Cancer;   Gynecologic Cancer;   Brain Tumor;   Brain Cancer;   Gynecologic Tumor;   Prostate Tumor;   Prostate Neoplasm;   Breast Tumor;   Radiation Toxicity;   Quality of Life;   Rectal Cancer;   Rectal Tumor;   Rectal Neoplasms;   Lung Cancer;   Lung Tumor;   Lung Neoplasm;   Esophageal Cancer;   Esophagus Cancer;   Esophageal Tumor;   Esophageal Neoplasm;   Esophagus Tumor;   Esophagus Neoplasm;   Pancreatic Cancer;   Pancreatic Tumor;   Pancreatic Neoplasms;   Head and Neck Cancer;   Head and Neck Neoplasms;   Head and Neck Tumor;   Tumor;   Neoplasms;   Bladder Cancer;   Bladder Neoplasm;   Liver Cancer;   Liver Neoplasms;   Liver Metastases;   Oligometastases
    Intervention:   Radiation: Radiation therapy
    Sponsors:   UMC Utrecht;   The Netherlands Cancer Institute;   Sunnybrook Health Sciences Centre;   M.D. Anderson Cancer Center;   The Christie NHS Foundation Trust;   Royal Marsden NHS Foundation Trust;   Medical College of Wisconsin;   Elekta
    Recruiting

  • Conditions:   Esophageal Neoplasms;   Cancer of Esophagus;   Cancer of the Esophagus;   Esophageal Cancer;   Esophagus Cancer;   Neoplasm, Esophageal;   Esophagectomy
    Intervention:   Other: Mayo Clinic Conduit Report Card Questionnaires
    Sponsor:   Mayo Clinic
    Recruiting

  • Condition:   Esophageal Disease
    Intervention:  
    Sponsors:   University Hospital, Lille;   French Eso-Gastric Tumors Working Group;   National Cancer Institute, France
    Recruiting

  • Conditions:   Cancer;   Cancer of Pancreas;   Cancer of Liver;   Cancer of Esophagus;   Cancer of Stomach;   Cancer, Metastatic
    Intervention:  
    Sponsor:   Rigshospitalet, Denmark
    Recruiting

  • Conditions:   Esophageal Cancer;   GastroEsophageal Cancer
    Interventions:   Drug: APX005M;   Radiation: Radiation Therapy;   Drug: Paclitaxel;   Drug: Carboplatin;   Procedure: Surgical resection of tumor
    Sponsors:   University of California, San Francisco;   Apexigen, Inc.
    Recruiting

  • Conditions:   Adenocarcinoma;   Adenocystic Carcinoma;   Anal Cancer;   Appendix Cancer;   Brain Tumor;   Glioblastoma;   Astrocytoma;   Bile Duct Cancer;   Cholangiocarcinoma;   Bladder Cancer;   Bone Cancer;   Synovial Sarcoma;   Chondrosarcoma;   Liposarcoma;   Sarcoma, Kaposi;   Sarcoma,Soft Tissue;   Sarcoma;   Osteosarcoma;   CNS Cancer;   Brain Stem Neoplasms;   Breast Cancer;   Cervical Cancer;   Colorectal Cancer;   Rectal Cancer;   Colon Cancer;   Esophageal Cancer;   Esophagus Cancer;   Cancer of Colon;   Pancreatic Cancer;   Cancer of Pancreas;   Testis Cancer;   Testicular Cancer;   Ureter Cancer;   Renal Cell Carcinoma;   Kidney Cancer;   Gestational Trophoblastic Tumor;   Head and Neck Neoplasms;   Parotid Tumor;   Larynx Cancer;   Tongue Cancer;   Pharynx Cancer;   Salivary Gland Cancer;   Acute Myeloid Leukemia;   Chronic Myeloid Leukemia;   Acute Lymphoblastic Leukemia;   Multiple Myeloma;   Non Hodgkin Lymphoma;   Carcinoid Tumor;   Lung Cancer;   Neuroendocrine Tumors;   Mesothelioma;   Thyroid Cancer;   Parathyroid Neoplasms;   Adrenal Cancer;   Small Bowel Cancer;   Stomach Cancer;   Liver Cancer;   Hepatic Cancer;   Melanoma;   Skin Cancer;   Unknown Primary Tumors;   Uterine Cancer;   Fallopian Tube Cancer;   Ovarian Cancer;   Prostate Cancer;   Vaginal Cancer;   Penile Cancer;   Vulvar Cancer;   Waldenstrom Macroglobulinemia;   Cancer, Advanced;   Thymus Cancer;   Nasopharyngeal Carcinoma;   Multiple Endocrine Neoplasia;   Pheochromocytoma;   Small Cell Carcinoma;   Pulmonary Carcinoma
    Interventions:   Diagnostic Test: Testing: Genome;   Diagnostic Test: Testing: Transcriptome;   Diagnostic Test: Testing: Proteome;   Drug: Treatment: CAR-T
    Sponsor:   Taproot Health
    Not yet recruiting

  • Conditions:   Breast Cancer;   Pancreas Cancer;   Prostate Cancer;   Lung Cancer;   Colon Cancer;   Esophagus Cancer;   Liver Cancer;   Ovary Cancer;   Lymphoma
    Intervention:   Drug: NP-G2-044
    Sponsors:   Novita Pharmaceuticals, Inc.;   Translational Drug Development
    Recruiting

  • Conditions:   Head and Neck Cancer;   Head and Neck Squamous Cell Carcinoma;   Head and Neck Carcinoma;   Head and Neck Cancer Stage III;   Head and Neck Cancer Stage IV;   Head and Neck Cancer Metastatic;   Cancer;   Cancer of Esophagus;   Cancer, Metastatic;   Cancer of Head and Neck;   Cancer of Mouth;   Cancer of Neck
    Interventions:   Drug: Pembrolizumab;   Drug: Tadalafil
    Sponsor:   University of California, San Diego
    Not yet recruiting

  • Conditions:   Cancer, All Types;   Cancer of Liver;   Cancer of Stomach;   Cancer of Head and Neck;   Cancer of Rectum;   Cancer of Kidney;   Cancer of Esophagus;   Cancer of Colon;   Cancer Skin;   Cancer of Cervix;   Cancer, Metastatic;   Cancer of Larynx;   Cancer of Neck;   Cancer of Lung;   Cancer of Brain and Nervous System;   Cancer of Vulva, Disseminated;   Cancer of Pancreas;   Sarcoma;   GIST;   Small-cell Lung Cancer;   Adenocarcinoma Lung;   Cancer of Prostate;   Cancer, Advanced;   Adrenal Cancer;   Testicular Cancer;   Uterine Cancer;   Bronchoalveolar Cell Lung Cancer;   Cancer Unknown Primary;   Glioblastoma Multiforme;   Oligodendroglioma;   Breast Cancer;   Renal Cell Carcinoma;   Hepatocellular Carcinoma;   Cholangiocarcinoma;   Squamous Cell Carcinoma;   Transitional Cell Carcinoma;   Cancer, Other;   Cancer, Anal;   Melanoma;   Cancer, Bile Duct;   Cancer, Bladder;   Cancer Cords Vocal;   Cancers Cell Neuroendocrine;   Cancer Differentiated Poorly;   Cancer, Anaplastic Thyroid
    Intervention:  
    Sponsors:   SpeciCare;   Dana-Farber Cancer Institute;   Kalispell Regional Medical Center;   Georgia Institute of Technology;   Ontario Institute for Cancer Research;   SEngine Precision Medicine;   Helomics
    Recruiting

  • Conditions:   Cancer, Metastatic;   Cancer;   Cancer of Pancreas;   Cancer of Liver;   Cancer of Stomach;   Cancer Liver;   Cancer of Rectum;   Cancer of Kidney;   Cancer of Esophagus;   Cancer of Cervix;   Cancer of Colon;   Cancer of Larynx;   Cancer, Lung;   Cancer, Breast;   Cancer, Advanced;   Cancer Prostate;   Cancer of Neck;   Cancer of Skin;   Neuroendocrine Tumors;   Carcinoma;   Mismatch Repair Deficiency;   BRCA Gene Rearrangement;   Non Hodgkin Lymphoma;   Leukemia;   Non Small Cell Lung Cancer;   Cholangiocarcinoma;   Glioblastoma;   Central Nervous System Tumor;   Melanoma;   Urothelial Carcinoma;   Bladder Cancer;   Ovarian Cancer;   Endometrial Cancer;   Testicular Cancer;   Breast Cancer
    Intervention:   Other: Clinical Trial Matching
    Sponsor:   Massive Bio, Inc.
    Recruiting

  • Conditions:   Cancer of Unknown Origin;   Cancer Refractory;   Cancer of Stomach;   Cancer Head Neck;   Cancer of Skin;   Cancer, Lung;   Cancer Colorectal;   Cancer of Esophagus;   Cancer, Bladder;   Cancer, Uterus;   Cancer Cervix;   Cancer Liver;   Cancer, Kidney;   Cancer, Breast;   Hematologic Neoplasms
    Intervention:   Other: Genomic testing
    Sponsors:   Arbeitsgemeinschaft medikamentoese Tumortherapie;   Roche Pharma AG
    Recruiting

  • Conditions:   Radiation Therapy;   Cancer;   Cancer of Anus;   Cancer of Bladder;   Cancer of Cervix;   Cancer of Colon;   Cancer of Rectum;   Cancer of Esophagus;   Cancer of Gallbladder;   Cancer of Liver;   Cancer of Ovary;   Cancer of Pancreas;   Cancer of Prostate;   Cancer of Kidney and Renal Pelvis;   Cancer of Stomach;   Cancer of Testis;   Cancer of Uterus;   Cancer of Uterus and Cervix;   Cancer of Kidney
    Intervention:  
    Sponsors:   DxTerity Diagnostics;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Anatomic Stage II Breast Cancer;   Anatomic Stage IIA Breast Cancer;   Anatomic Stage IIB Breast Cancer;   Anatomic Stage III Breast Cancer;   Anatomic Stage IIIA Breast Cancer;   Anatomic Stage IIIB Breast Cancer;   Anatomic Stage IIIC Breast Cancer;   Clinical Stage II Esophageal Adenocarcinoma;   Clinical Stage II Esophageal Squamous Cell Carcinoma;   Clinical Stage II Gastric Cancer;   Clinical Stage II Gastroesophageal Junction Adenocarcinoma;   Clinical Stage IIA Esophageal Adenocarcinoma;   Clinical Stage IIA Gastric Cancer;   Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma;   Clinical Stage IIB Esophageal Adenocarcinoma;   Clinical Stage IIB Gastric Cancer;   Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma;   Clinical Stage III Esophageal Adenocarcinoma;   Clinical Stage III Esophageal Squamous Cell Carcinoma;   Clinical Stage III Gastric Cancer;   Clinical Stage III Gastroesophageal Junction Adenocarcinoma;   Distal Esophagus Squamous Cell Carcinoma;   Esophageal Carcinoma;   Estrogen Receptor Negative;   HER2/Neu Negative;   Limited Stage Small Cell Lung Carcinoma;   Malignant Solid Neoplasm;   Non-Small Cell Lung Carcinoma;   Pancreatic Adenocarcinoma;   Pathologic Stage II Esophageal Adenocarcinoma;   Pathologic Stage II Esophageal Squamous Cell Carcinoma;   Pathologic Stage II Gastric Cancer;   Pathologic Stage II Gastroesophageal Junction Adenocarcinoma;   Pathologic Stage IIA Esophageal Adenocarcinoma;   Pathologic Stage IIA Esophageal Squamous Cell Carcinoma;   Pathologic Stage IIA Gastric Cancer;   Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma;   Pathologic Stage IIB Esophageal Adenocarcinoma;   Pathologic Stage IIB Esophageal Squamous Cell Carcinoma;   Pathologic Stage IIB Gastric Cancer;   Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma;   Pathologic Stage III Esophageal Adenocarcinoma;   Pathologic Stage III Esophageal Squamous Cell Carcinoma;   Pathologic Stage III Gastric Cancer;   Pathologic Stage III Gastroesophageal Junction Adenocarcinoma;   Pathologic Stage IIIA Esophageal Adenocarcinoma;   Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma;   Pathologic Stage IIIA Gastric Cancer;   Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma;   Pathologic Stage IIIB Esophageal Adenocarcinoma;   Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma;   Pathologic Stage IIIB Gastric Cancer;   Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma;   Pathologic Stage IIIC Gastric Cancer;   Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma;   Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma;   Postneoadjuvant Therapy Stage II Gastric Cancer;   Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma;   Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma;   Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma;   Postneoadjuvant Therapy Stage III Gastric Cancer;   Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma;   Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma;   Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma;   Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma;   Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma;   Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma;   Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma;   Progesterone Receptor Negative;   Prognostic Stage II Breast Cancer;   Prognostic Stage IIA Breast Cancer;   Prognostic Stage IIB Breast Cancer;   Prognostic Stage III Breast Cancer;   Prognostic Stage IIIA Breast Cancer;   Prognostic Stage IIIB Breast Cancer;   Prognostic Stage IIIC Breast Cancer;   Stage I Pancreatic Cancer;   Stage IA Pancreatic Cancer;   Stage IB Pancreatic Cancer;   Stage II Lung Cancer;   Stage II Pancreatic Cancer;   Stage IIA Lung Cancer;   Stage IIA Pancreatic Cancer;   Stage IIB Lung Cancer;   Stage IIB Pancreatic Cancer;   Stage III Lung Cancer;   Stage IIIA Lung Cancer;   Stage IIIB Lung Cancer;   Stage IIIC Lung Cancer;   Triple-Negative Breast Carcinoma
    Interventions:   Drug: Ifetroban Sodium;   Other: Placebo
    Sponsors:   Vanderbilt-Ingram Cancer Center;   Cumberland Pharmaceuticals
    Recruiting

  • Conditions:   Clinical Stage I Esophageal Adenocarcinoma AJCC v8;   Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8;   Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8;   Clinical Stage II Esophageal Adenocarcinoma AJCC v8;   Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8;   Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8;   Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8;   Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8;   Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8;   Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8;   Clinical Stage III Esophageal Adenocarcinoma AJCC v8;   Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8;   Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8;   Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8;   Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8;   Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8;   Pathologic Stage I Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8;   Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8;   Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8;   Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8;   Pathologic Stage II Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8;   Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8;   Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8;   Pathologic Stage III Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8;   Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8;   Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8;   Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8;   Postneoadjuvant Therapy Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8;   Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8;   Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8;   Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8;   Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8;   Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8;   Thoracic Esophagus Squamous Cell Carcinoma
    Interventions:   Drug: Carboplatin;   Procedure: Esophagectomy;   Radiation: Intensity-Modulated Radiation Therapy;   Drug: Paclitaxel;   Radiation: Proton Beam Radiation Therapy;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration
    Sponsors:   NRG Oncology;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   a. Colorectal Cancer;   b. High Grade Serous Ovarian Cancer;   c. Non Small-cell Lung Cancer (Squamous Cell Variant);   d. Squamous Carcinoma of the Oesophagus;   e. Squamous Carcinoma of the Head and Neck (HPV Negative);   f. Urothelial Cancer;   g. Breast Cancer (Triple Negative Type);   h. Pancreatic Cancer
    Intervention:   Drug: LY3143921 hydrate
    Sponsor:   Cancer Research UK
    Recruiting

  • Condition:   Video Capsule Endoscopy
    Intervention:  
    Sponsor:   Bács-Kiskun County Teaching Hospital
    Recruiting

  • Conditions:   Gastroesophageal Reflux;   GERD
    Interventions:   Procedure: Confocal endomicroscopy;   Procedure: Mucosal impedance;   Procedure: Research biopsies;   Procedure: Bravo ambulatory pH monitor
    Sponsor:   Mayo Clinic
    Recruiting

  • Condition:   Advanced Esophageal Cancer
    Interventions:   Biological: Anti-MUC1 CAR-T cells;   Biological: PD-1 knockout Engineered T cells;   Combination Product: CAR-T combined with PD-1 Knockout T cells
    Sponsors:   The First Affiliated Hospital of Guangdong Pharmaceutical University;   Guangzhou Anjie Biomedical Technology Co., Ltd.
    Recruiting

  • Conditions:   Esophageal Cancer;   Gastric Cancer
    Intervention:   Drug: Afatinib and Paclitaxel
    Sponsors:   Memorial Sloan Kettering Cancer Center;   Boehringer Ingelheim;   University of Southern California;   Dana-Farber Cancer Institute;   United States Department of Defense
    Recruiting

  • Condition:   Digestive System Neoplasm
    Intervention:   Other: Biological collection
    Sponsor:   Institut du Cancer de Montpellier - Val d'Aurelle
    Recruiting

  • Condition:   Esophageal Squamous Cell Carcinoma (ESCC)
    Interventions:   Drug: BGB-A317;   Drug: Paclitaxel, or Docetaxel, or Irinotecan
    Sponsor:   BeiGene
    Recruiting